Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03568019 · ClinicalTrials.gov registry record
PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors
A clinical trial of Cachexia; Cancer, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT03568019: Active study of Cachexia; Cancer, sponsored by University of Texas Southwestern Medical Center.
NCT03568019 is a study of Cachexia; Cancer that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 10,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03568019, a study of Cachexia; Cancer, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
PET has an established role in the initial staging of patients with newly diagnosed lung and gastrointestinal tumors.PET avidity is described with both maximum and mean standardized uptake values.Malignant cells have increased activity on PET, defined as the standardized uptake value (SUV), with increased uptake of FDG in tumor due to elevated levels of GLUT receptors, elevated intracellular levels of hexokinase and increased rates of glycolysis. However, there is a subset of patients with lung and gastrointestinal tumors that are not PET avid.These patients may present with clinically and systemically aggressive disease with a declining performance status and/or weight loss.
Primary Outcome
The goal of this assessment is to identify patients with lung and gastrointestinal tumors and collect the data on tumor stage location, histology, PET avidity, and weight loss/performance status so that it will be possible to correlate SUV values associated with cachexia by using CTCAE version 4.0 to collect and log AE and SAE related to cachexia.
Conditions Studied
Interventions
- OTHER Retrospective study
Study Locations (1)
Texas
- UT Southwestern Medical Centre - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2013-11-26 |
| Est. Completion | 2027-12-31 |
What the registry record for NCT03568019 still lists
NCT03568019 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Cachexia; Cancer appearing as the primary indexed condition, and to 1 intervention - of which Retrospective study is the first listed.
NCT03568019 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03568019 about?
NCT03568019 is a clinical study titled "PET Avidity in Cachexia-Inducing Lung and Gastrointestinal Tumors". PET has an established role in the initial staging of patients with newly diagnosed lung and gastrointestinal tumors.PET avidity is described with both maximum and mean standardized uptake values.Malignant cells have increased activity on PET, defined as the standardized uptake value (SUV), with inc...
What is the current status of trial NCT03568019?
This trial is currently active not recruiting. The enrollment target is 10,000 participants. The study started on 2013-11-26. Estimated completion is 2027-12-31.
What conditions does trial NCT03568019 study?
This clinical trial studies the following conditions: Cachexia; Cancer.
What interventions are being tested in trial NCT03568019?
The interventions under investigation include: Retrospective study (OTHER).
Who is sponsoring clinical trial NCT03568019?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03568019 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cachexia; Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI